Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases

The long-term efficacy and safety of adalimumab (ADA) for the treatment of intestinal Behcet’s disease (BD) in the clinical setting have not been evaluated previously. This retrospective study evaluated the 52-week efficacy of ADA in BD patients. A total of eight patients who were refractory to conv...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med Res
Main Authors: Tanida, Satoshi, Mizoshita, Tsutomu, Nishie, Hirotada, Ozeki, Keiji, Katano, Takahito, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Format: Artigo
Language:Inglês
Published: Elmer Press 2016
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780498/
https://ncbi.nlm.nih.gov/pubmed/26985255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2477w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items